Skip to main content

Table 2 CMR findings

From: Relationship between coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance and serum eicosapentaenoic acid

  All patients High EPA group Low EPA group * P value
  (n = 127) (n = 64) (n = 63)  
Cine CMR     
  LVEDVI, mL/m2 73.9 ± 24.9 71.7 ± 21.8 76.1 ± 27.7 0.33
  LVESVI, mL/m2 33.2 ± 19.9 31.0 ± 19.1 35.4 ± 20.7 0.21
  LVSVI, mL/m2 40.8 ± 10.5 40.8 ± 8.6 40.8 ± 12.3 0.98
  LVEF, % 57.1 ± 12.1 58.9 ± 11.7 55.3 ± 16.9 0.094
  LV mass index, g/m2 56.3 ± 16.9 57.8 ± 17.0 54.8 ± 16.9 0.32
Late Gadolinium enhanced CMR     
  Presence of LGE 66 (52%) 32 (50%) 34 (54%) 0.65
  LGE (%) 10.6 ± 14.2 9.0 ± 13.1 12.2 ± 15.2 0.21
  1. Values are presented as mean ± standard deviation (SD).
  2. * P value represents significance of difference between low EPA group and high EPA group.
  3. EPA, eicosapentaenoic acid; CMR, cardiovascular magnetic resonance; LV, left ventricle; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; SVI, stroke volume index; EF, ejection fraction; LGE, late gadolinium enhancement.